We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Failure of the Paul Glaucoma Implant occurred in 8% of ...

Two years ago, the 3-year results of the Ahmed Baerveldt Comparison (ABC) were released. For further follow-up, the study group is presenting the 5-year outcomes. A total of 276 patients initially ...

Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with glaucoma, expanding the company’s reach overseas. The green lights under ...

The US Food and Drug Administration (FDA) has approved an intracameral implant with 75 mcg of travoprost to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular ...

Fellowship-trained ophthalmologist expands access to advanced glaucoma care in Volusia County His extensive experience ...

Efficacy is higher for the Xen 45 gel stent implant as a standalone procedure than combined with cataract surgery. The Xen 45 gel stent implant provides effective, long-term treatment for open-angle ...

In case you missed it, Glaukos, a prominent player in the Microinvasive Glaucoma Surgery (MIGS) space completed a 15-year regulatory journey. The San Clemente, CA-based company won a nod from FDA for ...

While the Xen 45 gel stent implant showed beneficial long-term outcomes for the treatment of open-angle glaucoma, a substantial proportion of patients needed follow-up operations or bleb needling, ...

When considering performing glaucoma surgery in patients who are pregnant, ophthalmologists should weigh factors such as ...